MEA Throat Cancer Diagnostics Market - Industry Trends and Forecast to 2030

Description

List of Tables

Middle East and Africa throat cancer diagnostics market is projected to register a substantial CAGR of 5.8% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2023 to 2030.

Market Segmentation:

Middle East and Africa Throat Cancer Diagnostics Market, By Product Type (Instruments and Consumables & Accessories), Test Type (Imaging Test, Blood Test, Biopsy, and Others), Cancer Type (Pharyngeal Cancer and Laryngeal Cancer), Stages (Stage 0, Stage I, Stage II, Stage III and Stage IV), Age Group (30-65, 65 and above, 21-29 and Below 21), End User (Hospitals, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centres, Cancer Research Institutes and Others) and By Distribution Channel (Direct Tender and Retail Sales), Country (South Africa, Saudi Arabia, UAE, Egypt, Israel, the Rest of the Middle East and Africa) Industry Trends and Forecast to 2030.

Rise in healthcare expenditure for cancer diagnosis and treatment

Novel technological advancements in cancer diagnostics

Market Players:

Some of the key market players in Middle East and Africa throat cancer diagnostics market are listed below:

F. Hoffmann-La Roche Ltd.

FUJIFILM Corporation

Thermo Fisher Scientific Inc.

Koninklijke Philips N.V.

Merck KGaA

General Electric Company

Agilent Technologies, Inc.

Bio-Rad Laboratories, Inc.

Abbott

QIAGEN

Siemens Healthcare GmbH

Quest Diagnostics Incorporated

Hologic

PlexBio

1 INTRODUCTION 46

1.1 OBJECTIVES OF THE STUDY 46
1.2 MARKET DEFINITION 46
1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET 46
1.4 LIMITATIONS 48
1.5 MARKETS COVERED 48

2 MARKET SEGMENTATION 51

2.1 MARKETS COVERED 51
2.2 GEOGRAPHICAL SCOPE 52
2.3 YEARS CONSIDERED FOR THE STUDY 53
2.4 CURRENCY AND PRICING 53
2.5 DBMR TRIPOD DATA VALIDATION MODEL 54
2.6 MULTIVARIATE MODELLING 57
2.7 PRODUCT TYPE LIFELINE CURVE 57
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 58
2.9 DBMR MARKET POSITION GRID 59
2.10 MARKET END USER COVERAGE GRID 60
2.11 VENDOR SHARE ANALYSIS 61
2.12 SECONDARY SOURCES 62
2.13 ASSUMPTIONS 62

3 EXECUTIVE SUMMARY 63

4 PREMIUM INSIGHTS 66

4.1 PESTEL ANALYSIS 67
4.2 PORTER'S FIVE FORCES 68

5 INDUSTRY INSIGHTS 69

6 EPIDEMIOLOGY 70

7 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET, REGULATIONS 71

7.1 REGULATORY SCENARIO IN THE U.S 71
7.2 REGULATORY SCENARIO IN AUSTRALIA 72
7.3 REGULATORY SCENARIO IN JAPAN 72
7.4 REGULATORY SCENARIO IN CHINA 72

8 MARKET OVERVIEW 74

8.1 DRIVERS 76
- 8.1.1 GROWING PREVALENCE OF THROAT CANCER 76
- 8.1.2 NOVEL TECHNOLOGICAL ADVANCEMENTS IN THROAT CANCER DIAGNOSTICS 76
- 8.1.3 INCREASE IN AWARENESS REGARDING THROAT CANCER 77
8.2 RESTRAINTS 77
- 8.2.1 LATE DIAGNOSIS AND POOR PROGNOSIS OF THROAT CANCER 77
- 8.2.2 HIGH COST FOR THE INSTALLATION OF DIAGNOSTIC DEVICES. 77
8.3 OPPORTUNITIES 78
- 8.3.1 RISE IN HEALTHCARE EXPENDITURE FOR CANCER DIAGNOSIS AND TREATMENT 78
- 8.3.2 GOVERNMENT INITIATIVES TOWARD CANCER DIAGNOSTICS 79
- 8.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS 79
8.4 CHALLENGES 80
- 8.4.1 INCREASED COST, SAFETY, AND CONVENIENCE ISSUES 80
- 8.4.2 LACK OF SKILLED AND CERTIFIED PROFESSIONALS 80

9 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE 81

9.1 OVERVIEW 82
9.2 INSTRUMENTS 85
- 9.2.1 PATHOLOGY-BASED INSTRUMENTS 86
  - 9.2.1.1 PCR INSTRUMENTS 86
  - 9.2.1.2 SLIDE STAINING SYSTEMS 86
  - 9.2.1.3 TISSUE PROCESSING SYSTEMS 87
  - 9.2.1.4 CELL PROCESSORS 87
  - 9.2.1.5 OTHER PATHOLOGY-BASED INSTRUMENTS 87
- 9.2.2 IMAGING INSTRUMENTS 87
  - 9.2.2.1 ULTRASOUND SYSTEMS 87
  - 9.2.2.2 CT SYSTEMS 87
  - 9.2.2.3 MRI SYSTEMS 87
  - 9.2.2.4 OTHERS 88
- 9.2.3 BIOPSY INSTRUMENTS 88
- 9.2.4 OTHERS 88
9.3 CONSUMABLES & ACCESSORIES 88
- 9.3.1 KITS 89
  - 9.3.1.1 PCR KITS 89
  - 9.3.1.2 DNA POLYMERASE KITS 89
  - 9.3.1.3 NUCLEIC ACID ISOLATION KITS 89
  - 9.3.1.4 OTHERS 90
- 9.3.2 REAGENTS 90
  - 9.3.2.1 ASSAYS 90
  - 9.3.2.2 BUFFERS 90
  - 9.3.2.3 PRIMERS 90
  - 9.3.2.4 OTHERS 90
- 9.3.3 PROBES 90
- 9.3.4 OTHER CONSUMABLES 90

10 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE 91

10.1 OVERVIEW 92
10.2 IMAGING TEST 95
- 10.2.1 COMPUTED TOMOGRAPHY (CT) SCAN 96
- 10.2.2 MRI 96
- 10.2.3 CHEST X-RAY 96
- 10.2.4 POSITRON EMISSION TOMOGRAPHY (PET) SCAN 96
- 10.2.5 OTHERS 96
10.3 BLOOD TEST 96
- 10.3.1 BLOOD CHEMISTRY TESTS 98
- 10.3.2 COMPLETE BLOOD COUNT (CBC) 98
- 10.3.3 OTHERS 98
10.4 BIOPSY 98
- 10.4.1 ENDOSCOPIC BIOPSY 99
- 10.4.2 FINE NEEDLE ASPIRATION (FNA) BIOPSY 99
- 10.4.3 OTHERS 99
10.5 OTHERS 100

11 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE 101

11.1 OVERVIEW 102
11.2 PHARYNGEAL CANCER 105
- 11.2.1 NASOPHARYNGEAL CANCER 106
- 11.2.2 OROPHARYNGEAL CANCER 106
- 11.2.3 HYPOPHARYNGEAL CANCER 106
11.3 LARYNGEAL CANCER 107

12 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET, BY STAGES 108

12.1 OVERVIEW 109
12.2 STAGE III 112
12.3 STAGE II 112
12.4 STAGE IV 113
12.5 STAGE I 114
12.6 STAGE 0 115

13 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET, BY AGE 116

13.1 OVERVIEW 117
13.2 30-65 120
13.3 65 AND ABOVE 121
13.4 21-29 121
13.5 BELOW 21 122

14 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET, BY END USER 123

14.1 OVERVIEW 124
14.2 HOSPITALS 127
14.3 ASSOCIATED LABS 127
14.4 INDEPENDENT DIAGNOSTIC LABORATORIES 128
14.5 DIAGNOSTIC IMAGING CENTERS 129
14.6 CANCER RESEARCH INSTITUTES 130
14.7 OTHERS 131

15 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL 132

15.1 OVERVIEW 133
15.2 DIRECT TENDER 136
15.3 RETAIL SALES 137

16 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET, BY REGION 138

16.1 MIDDLE EAST AND AFRICA 139
- 16.1.1 SAUDI ARABIA 150
- 16.1.2 U.A.E 155
- 16.1.3 SOUTH AFRICA 160
- 16.1.4 EGYPT 165
- 16.1.5 ISRAEL 170
- 16.1.6 REST OF MIDDLE EAST AND AFRICA 175

17 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET, COMPANY LANDSCAPE 176

17.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 176

18 SWOT ANALYSIS 177

19 COMPANY PROFILE 178

19.1 F. HOFFMANN- LA ROCHE LTD 178
- 19.1.1 COMPANY SNAPSHOT 178
- 19.1.2 REVENUE ANALYSIS 178
- 19.1.3 COMPANY SHARE ANALYSIS 179
- 19.1.4 PRODUCT PORTFOLIO 179
- 19.1.5 RECENT DEVELOPMENT 179
19.2 FUJIFILM CORPORATION 180
- 19.2.1 COMPANY SNAPSHOT 180
- 19.2.2 REVENUE ANALYSIS 180
- 19.2.3 COMPANY SHARE ANALYSIS 181
- 19.2.4 PRODUCT PORTFOLIO 181
- 19.2.5 RECENT DEVELOPMENT 181
19.3 THERMO FISHER SCIENTIFIC INC. 182
- 19.3.1 COMPANY SNAPSHOT 182
- 19.3.2 REVENUE ANALYSIS 182
- 19.3.3 COMPANY SHARE ANALYSIS 183
- 19.3.4 PRODUCT PORTFOLIO 183
- 19.3.5 RECENT DEVELOPMENTS 183
19.4 CANON MEDICAL SYSTEMS CORPORATION 184
- 19.4.1 COMPANY SNAPSHOT 184
- 19.4.2 REVENUE ANALYSIS 184
- 19.4.3 COMPANY SHARE ANALYSIS 185
- 19.4.4 PRODUCT PORTFOLIO 185
- 19.4.5 RECENT DEVELOPMENT 185
19.5 KONINKLIJKE PHILIPS N.V. 186
- 19.5.1 COMPANY SNAPSHOT 186
- 19.5.2 REVENUE ANALYSIS 186
- 19.5.3 COMPANY SHARE ANALYSIS 187
- 19.5.4 PRODUCT PORTFOLIO 187
- 19.5.5 RECENT DEVELOPMENT 188
19.6 ABBOTT 189
- 19.6.1 COMPANY SNAPSHOT 189
- 19.6.2 REVENUE ANALYSIS 189
- 19.6.3 PRODUCT PORTFOLIO 190
- 19.6.4 RECENT DEVELOPMENTS 190
19.7 AGILENT TECHNOLOGIES, INC. 191
- 19.7.1 COMPANY SNAPSHOT 191
- 19.7.2 REVENUE ANALYSIS 191
- 19.7.3 PRODUCT PORTFOLIO 192
- 19.7.4 RECENT DEVELOPMENT 192
19.8 BD 193
- 19.8.1 COMPANY SNAPSHOT 193
- 19.8.2 REVENUE ANALYSIS 193
- 19.8.3 PRODUCT PORTFOLIO 194
- 19.8.4 RECENT DEVELOPMENTS 194
19.9 BEIJING O&D BIOTECH CO., LTD. 195
- 19.9.1 COMPANY SNAPSHOT 195
- 19.9.2 PRODUCT PORTFOLIO 195
- 19.9.3 RECENT DEVELOPMENT 195
19.10 BIO-RAD LABORATORIES, INC. 196
- 19.10.1 COMPANY SNAPSHOT 196
- 19.10.2 REVENUE ANALYSIS 196
- 19.10.3 PRODUCT PORTFOLIO 197
- 19.10.4 RECENT DEVELOPMENT 197
19.11 FONAR CORP. 198
- 19.11.1 COMPANY SNAPSHOT 198
- 19.11.2 REVENUE ANALYSIS 198
- 19.11.3 PRODUCT PORTFOLIO 199
- 19.11.4 RECENT DEVELOPMENT 199
19.12 GE HEALTHCARE 200
- 19.12.1 COMPANY SNAPSHOT 200
- 19.12.2 REVENUE ANALYSIS 200
- 19.12.3 PRODUCT PORTFOLIO 201
- 19.12.4 RECENT DEVELOPMENT 201
19.13 HOLOGIC INC. 202
- 19.13.1 COMPANY SNAPSHOT 202
- 19.13.2 REVENUE ANALYSIS 202
- 19.13.3 PRODUCT PORTFOLIO 203
- 19.13.4 RECENT DEVELOPMENT 203
19.14 ILLUMINA, INC. 204
- 19.14.1 COMPANY SNAPSHOT 204
- 19.14.2 REVENUE ANALYSIS 204
- 19.14.3 PRODUCT PORTFOLIO 205
- 19.14.4 RECENT DEVELOPMENT 205
19.15 MEDONICA CO. LTD 206
- 19.15.1 COMPANY SNAPSHOT 206
- 19.15.2 PRODUCT PORTFOLIO 206
- 19.15.3 RECENT DEVELOPMENT 206
19.16 MERCK KGAA 207
- 19.16.1 COMPANY SNAPSHOT 207
- 19.16.2 REVENUE ANALYSIS 207
- 19.16.3 PRODUCT PORTFOLIO 208
- 19.16.4 RECENT DEVELOPMENT 208
19.17 MINFOUND MEDICAL SYSTEMS CO., LTD 209
- 19.17.1 COMPANY SNAPSHOT 209
- 19.17.2 PRODUCT PORTFOLIO 209
- 19.17.3 RECENT DEVELOPMENT 209
19.18 MYRIAD GENETICS, INC. 210
- 19.18.1 COMPANY SNAPSHOT 210
- 19.18.2 REVENUE ANALYSIS 210
- 19.18.3 PRODUCT PORTFOLIO 211
- 19.18.4 RECENT DEVELOPMENT 211
19.19 PLEXBIO 212
- 19.19.1 COMPANY SNAPSHOT 212
- 19.19.2 PRODUCT PORTFOLIO 212
- 19.19.3 RECENT DEVELOPMENT 212
19.20 QIAGEN 213
- 19.20.1 COMPANY SNAPSHOT 213
- 19.20.2 REVENUE ANALYSIS 213
- 19.20.3 PRODUCT PORTFOLIO 214
- 19.20.4 RECENT DEVELOPMENT 214
19.21 QUEST DIAGNOSTICS INCORPORATED 215
- 19.21.1 COMPANY SNAPSHOT 215
- 19.21.2 REVENUE ANALYSIS 215
- 19.21.3 PRODUCT PORTFOLIO 216
- 19.21.4 RECENT DEVELOPMENT 216

19.22 SIEMENS HEALTHCARE GMBH 217
- 19.22.1 COMPANY SNAPSHOT 217
- 19.22.2 REVENUE ANALYSIS 217
- 19.22.3 PRODUCT PORTFOLIO 218
- 19.22.4 RECENT DEVELOPMENT 218
19.23 STERNMED GMBH 219
- 19.23.1 COMPANY SNAPSHOT 219
- 19.23.2 PRODUCT PORTFOLIO 219
- 19.23.3 RECENT DEVELOPMENT 219
19.24 TIME MEDICAL HOLDING. 220
- 19.24.1 COMPANY SNAPSHOT 220
- 19.24.2 PRODUCT PORTFOLIO 220
- 19.24.3 RECENT DEVELOPMENT 220

20 QUESTIONNAIRE 221

21 RELATED REPORTS 225

LIST OF TABLES

TABLE 1 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 60
TABLE 2 MIDDLE EAST & AFRICA INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 61
TABLE 3 MIDDLE EAST & AFRICA INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 62
TABLE 4 MIDDLE EAST & AFRICA PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 62
TABLE 5 MIDDLE EAST & AFRICA IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 63
TABLE 6 MIDDLE EAST & AFRICA CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 64
TABLE 7 MIDDLE EAST & AFRICA CONSUMABLES AND ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 65
TABLE 8 MIDDLE EAST & AFRICA KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 65
TABLE 9 MIDDLE EAST & AFRICA REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 66
TABLE 10 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 70
TABLE 11 MIDDLE EAST & AFRICA IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 71
TABLE 12 MIDDLE EAST & AFRICA IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 72
TABLE 13 MIDDLE EAST & AFRICA BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 73
TABLE 14 MIDDLE EAST & AFRICA BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 73
TABLE 15 MIDDLE EAST & AFRICA BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 74
TABLE 16 MIDDLE EAST & AFRICA BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 75
TABLE 17 MIDDLE EAST & AFRICA OTHERS IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 76
TABLE 18 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 80
TABLE 19 MIDDLE EAST & AFRICA PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 81
TABLE 20 MIDDLE EAST & AFRICA PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 82
TABLE 21 MIDDLE EAST & AFRICA LARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 83
TABLE 22 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 87
TABLE 23 MIDDLE EAST & AFRICA STAGE III IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 88
TABLE 24 MIDDLE EAST & AFRICA STAGE II IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 89
TABLE 25 MIDDLE EAST & AFRICA STAGE IV IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 89
TABLE 26 MIDDLE EAST & AFRICA STAGE I IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 90
TABLE 27 MIDDLE EAST & AFRICA STAGE 0 IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 91
TABLE 28 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 95
TABLE 29 MIDDLE EAST & AFRICA 30-65 IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 96
TABLE 30 MIDDLE EAST & AFRICA 65 AND ABOVE IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 97
TABLE 31 MIDDLE EAST & AFRICA 21-29 IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 98
TABLE 32 MIDDLE EAST & AFRICA BELOW 21 IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 98
TABLE 33 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 102
TABLE 34 MIDDLE EAST & AFRICA HOSPITAL IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 103
TABLE 35 MIDDLE EAST & AFRICA ASSOCIATED LABS IN THROAT CANCER DIAGNOSTICS MARKET, 2021-2030 (USD MILLION) 104
TABLE 36 MIDDLE EAST & AFRICA INDEPENDENT DIAGNOSTIC LABORATORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 104
TABLE 37 MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING CENTERS IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 105
TABLE 38 MIDDLE EAST & AFRICA CANCER RESEARCH INSTITUTES IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 106
TABLE 39 MIDDLE EAST & AFRICA OTHERS IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 107
TABLE 40 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 111
TABLE 41 MIDDLE EAST & AFRICA DIRECT TENDER IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 112
TABLE 42 MIDDLE EAST & AFRICA RETAIL SALES IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 113
TABLE 43 MIDDLE EAST AND AFRICA THROAT CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 120
TABLE 44 MIDDLE EAST AND AFRICA THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 120
TABLE 45 MIDDLE EAST AND AFRICA INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 120
TABLE 46 MIDDLE EAST AND AFRICA PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 121
TABLE 47 MIDDLE EAST AND AFRICA IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 121
TABLE 48 MIDDLE EAST AND AFRICA CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 121
TABLE 49 MIDDLE EAST AND AFRICA KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 122
TABLE 50 MIDDLE EAST AND AFRICA REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 122
TABLE 51 MIDDLE EAST AND AFRICA THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 122
TABLE 52 MIDDLE EAST AND AFRICA IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 123
TABLE 53 MIDDLE EAST AND AFRICA BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 123
TABLE 54 MIDDLE EAST AND AFRICA BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 123
TABLE 55 MIDDLE EAST AND AFRICA THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 123
TABLE 56 MIDDLE EAST AND AFRICA PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 124
TABLE 57 MIDDLE EAST AND AFRICA THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 124
TABLE 58 MIDDLE EAST AND AFRICA THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 124
TABLE 59 MIDDLE EAST AND AFRICA THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 125
TABLE 60 MIDDLE EAST AND AFRICA THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 125
TABLE 61 SAUDI ARABIA THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 126
TABLE 62 SAUDI ARABIA INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 126
TABLE 63 SAUDI ARABIA PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 126
TABLE 64 SAUDI ARABIA IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 127
TABLE 65 SAUDI ARABIA CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 127
TABLE 66 SAUDI ARABIA KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 127
TABLE 67 SAUDI ARABIA REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 127
TABLE 68 SAUDI ARABIA THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 128
TABLE 69 SAUDI ARABIA IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 128
TABLE 70 SAUDI ARABIA BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 128
TABLE 71 SAUDI ARABIA BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 128
TABLE 72 SAUDI ARABIA THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 129
TABLE 73 SAUDI ARABIA PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 129
TABLE 74 SAUDI ARABIA THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 129
TABLE 75 SAUDI ARABIA THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 129
TABLE 76 SAUDI ARABIA THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 130
TABLE 77 SAUDI ARABIA THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 130
TABLE 78 U.A.E. THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 131
TABLE 79 U.A.E. INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 131
TABLE 80 U.A.E. PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 131
TABLE 81 U.A.E. IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 132
TABLE 82 U.A.E. CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 132
TABLE 83 U.A.E. KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 132
TABLE 84 U.A.E. REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 132
TABLE 85 U.A.E. THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 133
TABLE 86 U.A.E. IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 133
TABLE 87 U.A.E. BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 133
TABLE 88 U.A.E. BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 133
TABLE 89 U.A.E. THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 134
TABLE 90 U.A.E. PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 134
TABLE 91 U.A.E. THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 134
TABLE 92 U.A.E. THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 134
TABLE 93 U.A.E. THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 135
TABLE 94 U.A.E. THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 135
TABLE 95 SOUTH AFRICA THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 136
TABLE 96 SOUTH AFRICA INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 136
TABLE 97 SOUTH AFRICA PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 136
TABLE 98 SOUTH AFRICA IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 137
TABLE 99 SOUTH AFRICA CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 137
TABLE 100 SOUTH AFRICA KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 137
TABLE 101 SOUTH AFRICA REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 137
TABLE 102 SOUTH AFRICA THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 138
TABLE 103 SOUTH AFRICA IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 138
TABLE 104 SOUTH AFRICA BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 138
TABLE 105 SOUTH AFRICA BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 138
TABLE 106 SOUTH AFRICA THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 139
TABLE 107 SOUTH AFRICA PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 139
TABLE 108 SOUTH AFRICA THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 139
TABLE 109 SOUTH AFRICA THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 139
TABLE 110 SOUTH AFRICA THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 140
TABLE 111 SOUTH AFRICA THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 140
TABLE 112 EGYPT THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 141
TABLE 113 EGYPT INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 141
TABLE 114 EGYPT PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 141
TABLE 115 EGYPT IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 142
TABLE 116 EGYPT CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 142
TABLE 117 EGYPT KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 142
TABLE 118 EGYPT REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 142
TABLE 119 EGYPT THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 143
TABLE 120 EGYPT IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 143
TABLE 121 EGYPT BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 143
TABLE 122 EGYPT BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 143
TABLE 123 EGYPT THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 144
TABLE 124 EGYPT PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 144
TABLE 125 EGYPT THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 144
TABLE 126 EGYPT THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 144
TABLE 127 EGYPT THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 145
TABLE 128 EGYPT THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 145
TABLE 129 ISRAEL THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 146
TABLE 130 ISRAEL INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 146
TABLE 131 ISRAEL PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 146
TABLE 132 ISRAEL IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 147
TABLE 133 ISRAEL CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 147
TABLE 134 ISRAEL KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 147
TABLE 135 ISRAEL REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 147
TABLE 136 ISRAEL THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 148
TABLE 137 ISRAEL IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 148
TABLE 138 ISRAEL BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 148
TABLE 139 ISRAEL BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 148
TABLE 140 ISRAEL THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 149
TABLE 141 ISRAEL PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 149
TABLE 142 ISRAEL THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 149
TABLE 143 ISRAEL THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 149
TABLE 144 ISRAEL THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 150
TABLE 145 ISRAEL THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 150
TABLE 146 REST OF MIDDLE EAST AND AFRICA THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 151

LIST OF FIGURES

FIGURE 1 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET: SEGMENTATION 26
FIGURE 2 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET: DATA TRIANGULATION 29
FIGURE 3 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET: DROC ANALYSIS 30
FIGURE 4 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS 31
FIGURE 5 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS 31
FIGURE 6 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS 33
FIGURE 7 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID 34
FIGURE 8 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET: MARKET END USER COVERAGE GRID 35
FIGURE 9 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS 36
FIGURE 10 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET: SEGMENTATION 40
FIGURE 11 THE INCREASE IN THE AWARENESS ABOUT THROAT CANCER IS EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET GROWTH IN THE FORECAST PERIOD 41
FIGURE 12 THE INSTRUMENT TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET IN 2023 & 2030 41
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET 50
FIGURE 14 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, 2022 57
FIGURE 15 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION) 58
FIGURE 16 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, CAGR (2023-2030) 58
FIGURE 17 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, LIFELINE CURVE 59
FIGURE 18 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET: BY TEST TYPE, 2022 67
FIGURE 19 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET: BY TEST TYPE, 2023-2030 (USD MILLION) 68
FIGURE 20 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET: BY TEST TYPE, CAGR (2023-2030) 68
FIGURE 21 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET: BY TEST TYPE, LIFELINE CURVE 69
FIGURE 22 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, 2022 77
FIGURE 23 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, 2023-2030 (USD MILLION) 78
FIGURE 24 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, CAGR (2023-2030) 78
FIGURE 25 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, LIFELINE CURVE 79
FIGURE 26 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET: BY STAGES, 2022 84
FIGURE 27 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET: BY STAGES, 2023-2030 (USD MILLION) 85
FIGURE 28 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET: BY STAGES, CAGR (2023-2030) 85
FIGURE 29 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET: BY STAGES, LIFELINE CURVE 86
FIGURE 30 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET: BY AGE GROUP, 2022 92
FIGURE 31 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET: BY AGE GROUP, 2023-2030 (USD MILLION) 93
FIGURE 32 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET: BY AGE GROUP, CAGR (2023-2030) 93
FIGURE 33 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET: BY AGE GROUP, LIFELINE CURVE 94
FIGURE 34 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET: BY END USER, 2022 99
FIGURE 35 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET: BY END USER, 2023-2030 (USD MILLION) 100
FIGURE 36 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET: BY END USER, CAGR (2023-2030) 100
FIGURE 37 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET: BY END USER, LIFELINE CURVE 101
FIGURE 38 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2022 108
FIGURE 39 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION) 109
FIGURE 40 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 109
FIGURE 41 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 110
FIGURE 42 MIDDLE EAST AND AFRICA THROAT CANCER DIAGNOSTICS MARKET: SNAPSHOT (2022) 115
FIGURE 43 MIDDLE EAST AND AFRICA THROAT CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022) 117
FIGURE 44 MIDDLE EAST AND AFRICA THROAT CANCER DIAGNOSTICS MARKET: BY COUNTRY (2023 & 2030) 117
FIGURE 45 MIDDLE EAST AND AFRICA THROAT CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022 & 2030) 118
FIGURE 46 MIDDLE EAST AND AFRICA THROAT CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE (2023-2030) 118
FIGURE 47 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET: COMPANY SHARE 2022 (%) 151